尽管高管股票销售,但Thermo Fisher在2025年第四季度的收益估计超过了预期,并提高了股息,股票收益也出现了. Thermo Fisher beat earnings estimates in Q4 2025, raised its dividend, and saw stock gains despite executive share sales.

Thermo Fisher科学公司(TMO)报告,2025年Q4收入丰厚,达6.57 EPS,估计增加0.12美元,收入122.2亿美元,比上一年增加7.2%。 Thermo Fisher Scientific Inc. (TMO) reported strong Q4 2025 earnings with $6.57 EPS, beating estimates by $0.12, and revenue of $12.22 billion, up 7.2% year-over-year. 股票在第三季度上8.2%,主要是由于Lincluden管理有限公司的持股增加以及Holocene Advisors LP和NEOS Investment Management LLC的新投资. The stock rose 8.2% in the third quarter, driven by increased holdings from Lincluden Management Ltd. and new investments from Holocene Advisors LP and NEOS Investment Management LLC. CEO Marc Casper在3月4日出售了5,000股, 股份减少了3.88%, 执行副总裁Paul K. L. Chiu也出售股票。 CEO Marc Casper sold 5,000 shares on March 4, reducing his stake by 3.88%, while Executive Vice President Paul K. L. Chiu also sold shares. 该公司将季度股息提高到0.47美元,3月13日是退税日期,4月15日是付款日期。 The company raised its quarterly dividend to $0.47, with an ex-dividend date of March 13 and payment on April 15. 分析员维持“机动购买”共识评级,平均目标是633.68美元。 Analysts maintain a "Moderate Buy" consensus rating with an average target of $633.68.